These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27251791)

  • 1. Oral Metformin Ameliorates Bleomycin-Induced Skin Fibrosis.
    Ursini F; Grembiale RD; D'Antona L; Gallo E; D'Angelo S; Citraro R; Visca P; Olivieri I; De Sarro G; Perrotti N; Russo E
    J Invest Dermatol; 2016 Sep; 136(9):1892-1894. PubMed ID: 27251791
    [No Abstract]   [Full Text] [Related]  

  • 2. Methotrexate has no antifibrotic effect in bleomycin-induced experimental scleroderma.
    Ozgen M; Koca SS; Isik A; Ozercan IH
    J Rheumatol; 2010 Mar; 37(3):678-9. PubMed ID: 20197571
    [No Abstract]   [Full Text] [Related]  

  • 3. SKL-2841, a dual antagonist of MCP-1 and MIP-1 beta, prevents bleomycin-induced skin sclerosis in mice.
    Kimura M; Kawahito Y; Hamaguchi M; Nakamura T; Okamoto M; Matsumoto Y; Endo H; Yamamoto A; Ishino H; Wada M; Omoto A; Tsubouchi Y; Kohno M; Yoshikawa T
    Biomed Pharmacother; 2007 May; 61(4):222-8. PubMed ID: 17147981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secukinumab and metformin ameliorate dermal fibrosis by decreasing tissue interleukin-17 levels in bleomycin-induced dermal fibrosis.
    Karatas A; Celik C; Oz B; Akar ZA; Etem EO; Dagli AF; Koca SS
    Int J Rheum Dis; 2021 Jun; 24(6):795-802. PubMed ID: 33835703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifibrotic effect of lysophosphatidic acid receptors LPA1 and LPA3 antagonist on experimental murine scleroderma induced by bleomycin.
    Ohashi T; Yamamoto T
    Exp Dermatol; 2015 Sep; 24(9):698-702. PubMed ID: 25959255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formyl Peptide Receptor 2 Activation Ameliorates Dermal Fibrosis and Inflammation in Bleomycin-Induced Scleroderma.
    Park GT; Kwon YW; Lee TW; Kwon SG; Ko HC; Kim MB; Kim JH
    Front Immunol; 2019; 10():2095. PubMed ID: 31552041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal model of sclerotic skin. III: Histopathological comparison of bleomycin-induced scleroderma in various mice strains.
    Yamamoto T; Kuroda M; Nishioka K
    Arch Dermatol Res; 2000 Nov; 292(11):535-41. PubMed ID: 11194891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The specific free radical scavenger edaravone suppresses fibrosis in the bleomycin-induced and tight skin mouse models of systemic sclerosis.
    Yoshizaki A; Yanaba K; Ogawa A; Iwata Y; Ogawa F; Takenaka M; Shimizu K; Asano Y; Kadono T; Sato S
    Arthritis Rheum; 2011 Oct; 63(10):3086-97. PubMed ID: 21618208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UVA irradiation following treatment with topical 8-methoxypsoralen improves bleomycin-induced scleroderma in a mouse model, by reducing the collagen content and collagen gene expression levels in the skin.
    Hayashi S; Ikeda M; Kitamura Y; Hamasaki Y; Hatamochi A
    J Dermatol Sci; 2012 Jul; 67(1):20-5. PubMed ID: 22486844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of interferon-gamma on experimental scleroderma induced by bleomycin.
    Yamamoto T; Takagawa S; Kuroda M; Nishioka K
    Arch Dermatol Res; 2000 Jul; 292(7):362-5. PubMed ID: 10966061
    [No Abstract]   [Full Text] [Related]  

  • 11. Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma.
    Yamamoto T; Takagawa S; Katayama I; Yamazaki K; Hamazaki Y; Shinkai H; Nishioka K
    J Invest Dermatol; 1999 Apr; 112(4):456-62. PubMed ID: 10201529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of autoimmunity in a bleomycin-induced murine model of experimental systemic sclerosis: an important role for CD4+ T cells.
    Ishikawa H; Takeda K; Okamoto A; Matsuo S; Isobe K
    J Invest Dermatol; 2009 Jul; 129(7):1688-95. PubMed ID: 19158840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirt1 ameliorates systemic sclerosis by targeting the mTOR pathway.
    Zhu X; Chu H; Jiang S; Liu Q; Liu L; Xue Y; Zheng S; Wan W; Qiu J; Wang J; Zou H
    J Dermatol Sci; 2017 Aug; 87(2):149-158. PubMed ID: 28532580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spleen tyrosine kinase (Syk) inhibitor fostamatinib limits tissue damage and fibrosis in a bleomycin-induced scleroderma mouse model.
    Pamuk ON; Can G; Ayvaz S; Karaca T; Pamuk GE; Demirtas S; Tsokos GC
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S15-22. PubMed ID: 26148346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis.
    Huang J; Beyer C; Palumbo-Zerr K; Zhang Y; Ramming A; Distler A; Gelse K; Distler O; Schett G; Wollin L; Distler JH
    Ann Rheum Dis; 2016 May; 75(5):883-90. PubMed ID: 25858641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma.
    Vorstenbosch J; Al-Ajmi H; Winocour S; Trzeciak A; Lessard L; Philip A
    Arthritis Rheum; 2013 May; 65(5):1378-83. PubMed ID: 23436317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical vitamin D analogue calcipotriol reduces skin fibrosis in experimental scleroderma.
    Usategui A; Criado G; Del Rey MJ; Faré R; Pablos JL
    Arch Dermatol Res; 2014 Oct; 306(8):757-61. PubMed ID: 24788893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal models of scleroderma.
    Lakos G; Takagawa S; Varga J
    Methods Mol Med; 2004; 102():377-93. PubMed ID: 15286396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of skin sclerosis by 15deoxy delta12,14-prostaglandin J2 and retrovirally transfected prostaglandin D synthase in a mouse model of bleomycin-induced scleroderma.
    Kohno S; Endo H; Hashimoto A; Hayashi I; Murakami Y; Kitasato H; Kojima F; Kawai S; Kondo H
    Biomed Pharmacother; 2006 Jan; 60(1):18-25. PubMed ID: 16337105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Protective Effects of Bevacizumab in Bleomycin-Induced Experimental Scleroderma.
    Koca SS; Ozgen M; Dagli AF; Gozel N; Ozercan IH; Isik A
    Adv Clin Exp Med; 2016; 25(2):249-53. PubMed ID: 27627557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.